University/Organization: International Institute of Medicine and Science
Country: United States
Dr. Alain L Fymat is a medical scientist and an educator. He was educated at the University of Paris-Sorbonne and the University of California at Los Angeles. He is the current President/CEO and Professor at the International Institute of Medicine and Science with a previous appointment as Executive Vice President, Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine. He was formerly Professor of Radiology, Radiological Sciences, Radiation Medicine (Oncology), Critical Care Medicine, and Physics at several U.S. and European Universities. Previously, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs, Veterans Health Administration (Office of Research Oversight), and Director of the Magnetic Resonance Imaging Center and for a time Acting Chair of Radiology at its Loma Linda, California Medical Center. He has extensively published (in excess of 380 publications including patents, books & monographs, book chapters, refereed articles) and has lectured extensively in the USA, Europe, Africa and Asia. He has been the recipient of numerous research grants from government, academia and private industry, and has consulted extensively with these entities. He is Editor-in-Chief, Honorable Editor or Editor of 14 scientific/medical Journals.
Dr. Fymat’s current research interests lie at the interface between science and medicine, particularly molecular/personal/precision medicine, nanomedicine, human genetics/epigenetics/ecogenetics, and pharmacogenomics. His most recent publications deal with nanoneurology, nanooncology, nanochemotherapy, natural and synthetic immunotherapy, immunotherapy of brain cancers and neurological and inflammatory disorders, surgical and nonsurgical management and treatment of glioblastomas and other brain tumors, and drug delivery including across the brain protective barriers.
Scientia Ricerca is licensed and content of this site is available under a Creative Commons Attribution 4.0 International License.